PL1638416T3 - Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej - Google Patents

Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej

Info

Publication number
PL1638416T3
PL1638416T3 PL04763015T PL04763015T PL1638416T3 PL 1638416 T3 PL1638416 T3 PL 1638416T3 PL 04763015 T PL04763015 T PL 04763015T PL 04763015 T PL04763015 T PL 04763015T PL 1638416 T3 PL1638416 T3 PL 1638416T3
Authority
PL
Poland
Prior art keywords
barrier function
nutritional formula
gut barrier
optimal gut
optimal
Prior art date
Application number
PL04763015T
Other languages
English (en)
Inventor
Clara Lucia Garcia-Rodenas
Gabriela Bergonzelli
Florence Rochat
Marco Enrico Turini
Irene Corthesy-Theulaz
Christine Cherbut
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL1638416T3 publication Critical patent/PL1638416T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
  • Fodder In General (AREA)
PL04763015T 2003-06-23 2004-06-22 Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej PL1638416T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03014040 2003-06-23
EP04763015.7A EP1638416B1 (en) 2003-06-23 2004-06-22 Use of a nutritional formula for optimal gut barrier function
PCT/EP2004/006736 WO2004112509A2 (en) 2003-06-23 2004-06-22 Nutritional formula for optimal gut barrier function

Publications (1)

Publication Number Publication Date
PL1638416T3 true PL1638416T3 (pl) 2013-09-30

Family

ID=33522258

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04763015T PL1638416T3 (pl) 2003-06-23 2004-06-22 Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej

Country Status (10)

Country Link
US (1) US8394370B2 (pl)
EP (1) EP1638416B1 (pl)
CN (1) CN1863463B (pl)
AR (1) AR044888A1 (pl)
CA (1) CA2530437C (pl)
ES (1) ES2416287T3 (pl)
PL (1) PL1638416T3 (pl)
PT (1) PT1638416E (pl)
TW (1) TWI342779B (pl)
WO (1) WO2004112509A2 (pl)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US20080015166A1 (en) * 2004-06-22 2008-01-17 N.V. Nutricia Barrier Integrity in Hiv Patients
WO2006000992A1 (en) 2004-06-23 2006-01-05 L'oreal Method and compositions useful for preventing and/or treating sensitive and/or dry skin
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
DE602004021734D1 (de) 2004-11-18 2009-08-06 Nutricia Nv Verdickungsmittelzusammensetzung für dysphagia-patienten
EP1926395A1 (en) 2005-04-13 2008-06-04 Nestec S.A. Infant formula with probiotics
CA2604383C (en) * 2005-04-27 2014-09-09 N.V. Nutricia Nutrition with lipids and non-digestible saccharides
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
WO2006132968A1 (en) * 2005-06-06 2006-12-14 Bristol-Myers Squibb Company Low-phytate infant formulas
NO323665B1 (no) * 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
US20090203592A1 (en) * 2005-07-01 2009-08-13 N.V. Nutricia Infant nutrition with hydrolised proteins
WO2007035870A2 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
RU2445360C2 (ru) * 2005-10-05 2012-03-20 Нестек С.А. Композиция для компенсации задержки роста
AU2015218488B2 (en) * 2005-10-21 2017-02-02 N.V. Nutricia Method for stimulating the intestinal flora
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
RU2445362C2 (ru) * 2006-02-15 2012-03-20 Нестек С.А. Применение bifidobacterium longum в производстве лекарственного средства или терапевтической питательной композиции для лечения воспалительного заболевания кишечника у млекопитающего и для ослабления воспаления кишечника, связанного с пищевыми аллергенами, у млекопитающего
US20090305996A1 (en) * 2006-03-10 2009-12-10 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
MX295615B (es) * 2006-04-11 2012-02-07 Market Biosciences Corp Productos alimenticios que comprenden acidos grasos poliinsaturados de cadena largay metodos para preparar los mismos.
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
DK3485742T3 (da) * 2006-11-29 2021-11-15 Prolacta Bioscience Inc Modermælkssammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
US8377445B2 (en) 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
ES2668552T3 (es) * 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
JP2009102292A (ja) * 2007-04-27 2009-05-14 Chiba Prefecture ストレス抑制剤
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
BRPI0820175B8 (pt) * 2007-11-08 2022-11-22 Nestec Sa uso de oligossacarídeos contendo n-acetillactosamina para maturação de respostas imunes em neonatos.
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
MX2010007646A (es) * 2008-01-28 2010-08-03 Mead Johnson Nutrition Co Composicion nutritiva que contiene acido docosahexanoico, acido rumenico, y gangliosidos.
NL2001377C2 (nl) * 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.
US9439885B2 (en) * 2008-06-03 2016-09-13 Mead Johnson Nutrition Company Method for inhibiting the growth of bacteria
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
AR072142A1 (es) * 2008-06-13 2010-08-11 Nutricia Nv Nutricion para prevenir infecciones.proceso. composicion. uso.
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
ES2719096T3 (es) * 2008-11-21 2019-07-08 Cruz Serrano Jose Antonio Método para obtener una mezcla de probióticos, prebióticos nutrientes con acción simbiótica sinérgica
CN102300575A (zh) * 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) * 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
CN102802439A (zh) * 2009-04-15 2012-11-28 N.V.努特里奇亚 抗反流婴儿营养物
MX338680B (es) * 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9226521B2 (en) 2009-12-08 2016-01-05 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
NL2004201C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
DK2563167T3 (en) 2010-04-26 2015-05-18 Enzymotec Ltd PRACTICES AND lipid TO PROMOTE DEVELOPMENT OF INTESTINAL FLORA
WO2011136636A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
CN106072654A (zh) * 2010-04-27 2016-11-09 N·V·努特里奇亚 6’‑唾液酸化乳糖在婴儿和幼儿营养物中的用途
WO2011148221A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
BR112013017021A2 (pt) * 2010-12-29 2019-09-24 Nestec Sa composição nutricional compreendendo fibra e probióticos para reduzir os sintomas intestinais realacionados ao estresse
CA2822222C (en) 2010-12-31 2019-05-07 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MY166946A (en) 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
MX355780B (es) * 2010-12-31 2018-04-30 Abbott Lab Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
CN103763940B (zh) * 2010-12-31 2015-10-14 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
EP3510873A1 (en) 2010-12-31 2019-07-17 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
MX345413B (es) 2011-02-10 2017-01-27 Nestec Sa Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.
WO2012118535A1 (en) * 2011-03-01 2012-09-07 Quorum Innovations, Llc Materials and methods for treating conditions associated with pathogenic biofilm
WO2012140118A1 (en) * 2011-04-12 2012-10-18 Nestec S.A. Nutritional compositions including branched chain fatty acids for wound healing
ES3005933T3 (en) 2011-06-20 2025-03-17 Heinz Co Brands H J Llc Probiotic compositions and methods
US20140170126A1 (en) * 2011-07-12 2014-06-19 Nestec S.A. Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs
WO2013016111A1 (en) * 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
DK2739157T3 (en) 2011-08-03 2018-01-08 Prolacta Bioscience Inc Microfiltration of human milk to reduce bacterial contamination
MX368124B (es) 2011-08-29 2019-09-19 Abbott Lab Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
PH12014500509B1 (en) 2011-10-18 2019-02-13 Nestec Sa Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
EP2775852B1 (en) * 2011-10-18 2016-08-17 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
WO2013126015A1 (en) * 2012-02-23 2013-08-29 N. V. Nutricia Composition comprising non- digestible oligosaccharides
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
US20140037813A1 (en) * 2012-08-02 2014-02-06 Mead Johnson Nutrition Company Nutritional creamer composition
CN104968216A (zh) * 2012-12-10 2015-10-07 N·V·努特里奇亚 含有非消化性寡糖的营养组合物
CA2893217C (en) * 2012-12-18 2017-11-28 Abbott Laboratories Human milk oligosaccharides to ameliorate symptoms of stress
US20140251944A1 (en) * 2013-03-08 2014-09-11 Nelson Jesus Spinetti Happy baby bottle
CN105246342A (zh) 2013-03-13 2016-01-13 普罗莱克塔生物科学公司 高脂人乳产品
EP3079502A1 (en) 2013-11-04 2016-10-19 N.V. Nutricia Fermented formula with non digestible oligosaccharides
WO2015077233A1 (en) 2013-11-19 2015-05-28 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
WO2015085549A1 (en) 2013-12-12 2015-06-18 Nestec S.A. An age-tailored nutrition system for an infant
CN104041906A (zh) * 2014-06-27 2014-09-17 施文康 一种断奶饮料的制作方法
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
SG11201805635RA (en) 2015-12-30 2018-07-30 Prolacta Bioscience Inc Human milk products useful in pre- and post-operative care
US20180103675A1 (en) * 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
CN108813262A (zh) * 2018-07-02 2018-11-16 杭州相生相成科技有限公司 一种含dha藻油的复合益生菌固体饮料
US20220062311A1 (en) 2018-12-21 2022-03-03 Societe Des Produits Nestle S.A. A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
IT201900000043A1 (it) * 2019-01-03 2020-07-03 Watt S R L Sostituto della prima colazione
WO2020156679A1 (en) * 2019-02-01 2020-08-06 Adisseo France S.A.S. Use of a thraustochytrid biomass for maintaining gut barrier function
EP3968787A1 (en) * 2019-05-15 2022-03-23 N.V. Nutricia Fermented formula for improving intestinal development
EP4151097A1 (en) * 2019-06-04 2023-03-22 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and dietary butyrate
EP4286014A3 (en) 2019-06-04 2024-02-21 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
BR112022005578A2 (pt) 2019-09-24 2022-09-20 Prolacta Bioscience Inc Composições e métodos para tratamento de doenças inflamatórias e imunes
CN110742275A (zh) * 2019-09-30 2020-02-04 北京斯利安药业有限公司 一种dha蛋黄粉及其制备方法与应用
CN116103160B (zh) * 2022-10-20 2025-04-11 生物源生物技术（深圳）股份有限公司 一种食用菌菌丝体发酵液的制备方法、发酵液及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
JPH0530942A (ja) * 1991-07-25 1993-02-09 Riyoushiyoku Kenkyukai 高分子の腸管透過性を制御する効果のある 飲食品及び医薬品
ES2110986T3 (es) 1991-08-12 1998-03-01 Nestle Sa Composicion alimenticia.
JP3002850B2 (ja) 1992-03-31 2000-01-24 雪印乳業株式会社 ガングリオシドｇｍ３配合栄養組成物
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6132710A (en) 1997-03-17 2000-10-17 Probiotix, Inc. Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
HUP0003995A3 (en) * 1997-07-05 2002-01-28 Nestle Sa Absorption of minerals by intestinal cells
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
AUPP327198A0 (en) * 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
AU3119600A (en) * 1998-12-15 2000-07-03 American Home Products Corporation Method and composition for the maintenance and restitution of gut integrity
JP3411965B2 (ja) 1999-06-30 2003-06-03 雪印乳業株式会社 ポリアミン含有組成物の製造方法
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
EP1261355B1 (en) * 2000-03-01 2004-12-01 Société des Produits Nestlé S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
US20020044988A1 (en) 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
JP3853673B2 (ja) 2001-03-09 2006-12-06 森永乳業株式会社 Ｃ型慢性肝炎治療剤
EP1281325A1 (en) 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
ATE423475T1 (de) * 2001-11-12 2009-03-15 Mars Inc Nahrungsmittel für katzen und hunde

Also Published As

Publication number Publication date
WO2004112509A2 (en) 2004-12-29
EP1638416B1 (en) 2013-05-01
EP1638416A2 (en) 2006-03-29
CN1863463A (zh) 2006-11-15
US20070104700A1 (en) 2007-05-10
TWI342779B (en) 2011-06-01
CA2530437A1 (en) 2004-12-29
US8394370B2 (en) 2013-03-12
ES2416287T3 (es) 2013-07-31
AR044888A1 (es) 2005-10-05
PT1638416E (pt) 2013-07-08
CA2530437C (en) 2011-11-15
TW200507863A (en) 2005-03-01
CN1863463B (zh) 2011-05-04
WO2004112509A3 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
PL1638416T3 (pl) Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
GB0324886D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
PL370481A1 (pl) Sole walsartanu
GB0305927D0 (en) Compound
GB0306718D0 (en) Compound
GB0324792D0 (en) Compound
AP2005003329A0 (en) Chemically acidified formula
GB0328490D0 (en) Medicinal compounds
IL174213A0 (en) A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
GB0317841D0 (en) Compound
GB0317842D0 (en) Compound
GB0310361D0 (en) Pharmaceutical compound
GB0309120D0 (en) A set of parts
GB0324599D0 (en) Compound
EG23601A (en) A group of scessors for opening sermony
AU152187S (en) A trocar
GB0323215D0 (en) A spirometer
AU151659S (en) A wall plaque
AU151656S (en) A wall plaque
AU151655S (en) A wall plaque
AU151652S (en) A wall plaque
AU151653S (en) A wall plaque
AU151654S (en) A wall plaque
AU151657S (en) A wall plaque